Loading resource…

University College London, Imperial College London
Tuberculosis (TB) is the leading cause of infection-related mortality globally, with increasing cases reported in the United States. The article discusses the importance of screening high-risk individuals for asymptomatic TB infection and emphasizes the need for microbiological confirmation of TB disease. Treatment protocols are outlined, highlighting the necessity of multiple antibiotics and monitoring for drug toxicity. The content is aimed at improving patient outcomes and reducing transmission rates of TB.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

World Malaria Report 2020
Same clinical topic · Infectious Disease

PRIMER SYPHILIS
Same clinical topic · Infectious Disease

LEISHMANIASIS
Same clinical topic · Infectious Disease

SUPPLEMENTARY APPENDIX
Same clinical topic · Infectious Disease

Influenza
Same clinical topic · Infectious Disease

VARICELLA ZOSTER VIRUS INFECTION
Same clinical topic · Infectious Disease

RECENT ADVANCES IN THE TREATMENT OF MALARIA
Same clinical topic · Infectious Disease

DEFINING SEPSIS PAST, PRESENT, AND FUTURE
Same clinical topic · Infectious Disease

RAPID DIAGNOSIS OF SEPSIS AND BLOODSTREAM INFECTIONS
Same clinical topic · Infectious Disease